Early-phase benefits set the stage for repair rather than constituting repair itself
Bryant AM, Rose NB, Temkin NR, Barber JK, Manley GT, McCrea MA, et al
This is mechanistically distinct from amphetamine-class compounds: tesofensine doesn't release stored catecholamines
Animal LD50 studies showed toxic levels around 320 mg/kg body weight, translating to approximately 22,400 mg for a 70 kg human
BOC Sciences designs enzyme cleavable linkers with chemical modifications, peptide sequence optimization, and structural improvements to ensure high stability in the bloodstream and non-target cells, effectively preventing premature drug release in non-target tissues